Oxidative stress and epigenetic instability in human hepatocarcinogenesis

Digestive Diseases

Volumn 31, Issue 5-6, 2013, Pages 447-453

  Nishida, Naoshi ^a   Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA methylation; Epigenetic instability; Hepatocellular carcinoma; Histone; Oncogene; Oxidative stress; Reactive oxygen species; Tumor suppressor gene

Indexed keywords

CYTOKINE; CYTOSINE; CYTOSINE BINDING PROTEIN; DNA; HISTONE; METHYL GROUP; SATELLITE DNA; UNCLASSIFIED DRUG;

CHROMOSOMAL INSTABILITY; CHROMOSOME INACTIVATION; CONFERENCE PAPER; CPG ISLAND; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; EPIGENETICS; GENETIC TRANSCRIPTION; HEPATITIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LIVER CARCINOGENESIS; NONHUMAN; ONCOGENE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; ARTICLE; EPIGENETIC INSTABILITY; GENE EXPRESSION REGULATION; HEPATITIS C; HEPATITIS VIRUS; HYDROGEN BOND; LIVER CELL CARCINOMA; TRANSCRIPTION INITIATION;

CARCINOMA, HEPATOCELLULAR; CHROMOSOMAL INSTABILITY; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; LIVER NEOPLASMS; OXIDATIVE STRESS;

EID: 84890050468     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000355243     Document Type: Conference Paper

References (64)

1. Nishida N, Goel A: Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics 2011; 12: 130-137.
2. Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH: Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology 2012; 56: 1567-1574.
3. Kim DY, Han K: Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer 2012; 1: 2-14.
4. Ziech D, Franco R, Pappa A, Panayiotidis MI: Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 2011; 711: 167-173.
5. Murata M, Thanan R, Ma N, Kawanishi S: Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. J Biomed Biotechnol 2012; 2012: 623019.
6. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K: In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J Hepatol 2001; 35: 613-618.
7. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K: In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002; 37: 56-62.
8. Tanaka S, Miyanishi K, Kobune M, Kawano Y, Hoki T, Kubo T, Hayashi T, Sato T, Sato Y, Takimoto R, Kato J: Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. J Gastroenterol 2013, E-pub ahead of print.
9. Beard WA, Batra VK, Wilson SH: DNA polymerase structure-based insight on the mutagenic properties of 8-oxoguanine. Mutat Res 2010; 703: 18-23.
10. Totoki Y, Tatsuno K, Yamamoto S, Arai Y, Hosoda F, Ishikawa S, Tsutsumi S, Sonoda K, Totsuka H, Shirakihara T, Sakamoto H, Wang L, Ojima H, Shimada K, Kosuge T, Okusaka T, Kato K, Kusuda J, Yoshida T, Aburatani H, Shibata T: High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 2011; 43: 464-469.
11. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, Chisari FV: Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 1994; 91: 12808-12812.
12. Wang JH, Yun C, Kim S, Lee JH, Yoon G, Lee MO, Cho H: Reactive oxygen species modulates the intracellular level of HBx viral oncoprotein. Biochem Biophys Res Commun 2003; 310: 32-39.
13. Georgakilas AG, Mosley WG, Georgakila S, Ziech D, Panayiotidis MI: Viral-induced human carcinogenesis: an oxidative stress perspective. Mol Biosyst 2010; 6: 1162-1172.
14. Pal S, Polyak SJ, Bano N, Qiu WC, Carithers RL, Shuhart M, Gretch DR, Das A: Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. J Gastroenterol Hepatol 2010; 25: 627-634.
15. Maki A, Kono H, Gupta M, Asakawa M, Suzuki T, Matsuda M, Fujii H, Rusyn I: Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol 2007; 14: 1182-1190.
16. Pavio N, Romano PR, Graczyk TM, Feinstone SM, Taylor DR: Protein synthesis and endoplasmic reticulum stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation factor 2α kinase perk. J Virol 2003; 77: 3578-3585.
17. Tardif KD, Waris G, Siddiqui A: Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol 2005; 13: 159-163.
18. Sasaki Y: Does oxidative stress participate in the development of hepatocellular carcinoma? J Gastroenterol 2006; 41: 1135-1148.
19. Ma Y, Hendershot LM: The mammalian endoplasmic reticulum as a sensor for cellular stress. Cell Stress Chaperones 2002; 7: 222-229.
20. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-1067.
21. Korenaga M, Wang T, Li Y, Showalter LA, Chan T, Sun J, Weinman SA: Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005; 280: 37481-37488.
22. Gong G, Waris G, Tanveer R, Siddiqui A: Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc Natl Acad Sci USA 2001; 98: 9599-9604.
23. Lloyd DR, Phillips DH: Oxidative DNA damage mediated by copper(II), iron(II) and nickel(II) fenton reactions: evidence for sitespecific mechanisms in the formation of double-strand breaks, 8-hydroxydeoxyguanosine and putative intrastrand cross-links. Mutat Res 1999; 424: 23-36.
24. Furutani T, Hino K, Okuda M, Gondo T, Nishina S, Kitase A, Korenaga M, Xiao SY, Weinman SA, Lemon SM, Sakaida I, Okita K: Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 2006; 130: 2087-2098.
25. Yano M, Hayashi H, Yoshioka K, Kohgo Y, Saito H, Niitsu Y, Kato J, Iino S, Yotsuyanagi H, Kobayashi Y, Kawamura K, Kakumu S, Kaito M, Ikoma J, Wakusawa S, Okanoue T, Sumida Y, Kimura F, Kajiwara E, Sata M, Ogata K: A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol 2004; 39: 570-574.
26. Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, Sato Y, Fujikawa K, Takahashi M, Takayama T, Ikeda T, Niitsu Y: Normalization of elevated hepatic 8-hydroxy-2. ′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 2001; 61: 8697-8702.
27. Novitskiy G, Traore K, Wang L, Trush MA, Mezey E: Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. Alcohol Clin Exp Res 2006; 30: 1429-1435.
28. You JS, Jones PA: Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012; 22: 9-20.
29. Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G: Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008; 135: 2128-2140.
30. Kang KA, Zhang R, Kim GY, Bae SC, Hyun JW: Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumour Biol 2012; 33: 403-412.
31. O'Hagan HM, Wang W, Sen S, Destefano Shields C, Lee SS, Zhang YW, Clements EG, Cai Y, Van Neste L, Easwaran H, Casero RA, Sears CL, Baylin SB: Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG islands. Cancer Cell 2011; 20: 606-619.
32. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T: High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006; 12: 989-995.
33. Rosenberg DW, Giardina C, Tanaka T: Mouse models for the study of colon carcinogenesis. Carcinogenesis 2009; 30: 183-196.
34. Chiba T, Marusawa H, Ushijima T: Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology 2012; 143: 550-563.
35. Hmadcha A, Bedoya FJ, Sobrino F, Pintado E: Methylation-dependent gene silencing induced by interleukin 1β via nitric oxide production. J Exp Med 1999; 190: 1595-1604.
36. Hodge DR, Xiao W, Clausen PA, Heidecker G, Szyf M, Farrar WL: Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 2001; 276: 39508-39511.
37. Braconi C, Huang N, Patel T: Microrna-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2010; 51: 881-890.
38. Xia D, Wang D, Kim SH, Katoh H, DuBois RN: Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nature Med 2012; 18: 224-226.
39. Gasche JA, Hoffmann J, Boland CR, Goel A: Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 2011; 129: 1053-1063.
40. To KF, Chan MW, Leung WK, Ng EK, Yu J, Bai AH, Lo AW, Chu SH, Tong JH, Lo KW, Sung JJ, Chan FK: Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer 2004; 91: 1335-1341.
41. Isomoto H, Mott JL, Kobayashi S, Werneburg NW, Bronk SF, Haan S, Gores GJ: Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology 2007; 132: 384-396.
42. Wong NC, Wong LH, Quach JM, Canham P, Craig JM, Song JZ, Clark SJ, Choo KH: Permissive transcriptional activity at the centromere through pockets of DNA hypomethylation. PLoS Genet 2006; 2:e17.
43. Vera E, Canela A, Fraga MF, Esteller M, Blasco MA: Epigenetic regulation of telomeres in human cancer. Oncogene 2008; 27: 6817-6833.
44. Howard G, Eiges R, Gaudet F, Jaenisch R, Eden A: Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 2008; 27: 404-408.
45. Wainfan E, Poirier LA: Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res 1992; 52: 2071s-2077s.
46. Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, Szyf M: Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer Res 2011; 71: 5891-5903.
47. Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A, Le Coz M, Devarajan K, Wessels A, Soprano D, Abramowitz LK, Bartolomei MS, Rambow F, Bassi MR, Bruno T, Fanciulli M, Renner C, Klein-Szanto AJ, Matsumoto Y, Kobi D, Davidson I, Alberti C, Larue L, Bellacosa A: Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 2011; 146: 67-79.
48. Kato L, Begum NA, Burroughs AM, Doi T, Kawai J, Daub CO, Kawaguchi T, Matsuda F, Hayashizaki Y, Honjo T: Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes. Proc Natl Acad Sci USA 2012; 109: 2479-2484.
49. Ma DK, Guo JU, Ming GL, Song H: DNA excision repair proteins and Gadd45 as molecular players for active DNA demethylation. Cell Cycle 2009; 8: 1526-1531.
50. Goudar RK, Vlahovic G: Hypoxia, angiogenesis, and lung cancer. Curr Oncol Rep 2008; 10: 277-282.
51. Lawless MW, O'Byrne KJ, Gray SG: Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy. J Cell Mol Med 2009; 13: 2800-2821.
52. Pialoux V, Mounier R, Brown AD, Steinback CD, Rawling JM, Poulin MJ: Relationship between oxidative stress and HIF-1α mRNA during sustained hypoxia in humans. Free Radic Biol Med 2009; 46: 321-326.
53. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H, Poellinger L: Redoxregulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α. Mol Cell Biol 2000; 20: 402-415.
54. Ruas JL, Poellinger L, Pereira T: Functional analysis of hypoxia-inducible factor-1α-mediated transactivation: identification of amino acid residues critical for transcriptional activation and/or interaction with CREB binding protein. J Biol Chem 2002; 277: 38723-38730.
55. Xenaki G, Ontikatze T, Rajendran R, Stratford IJ, Dive C, Krstic-Demonacos M, Demonacos C: PCAF is an HIF-1α cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene 2008; 27: 5785-5796.
56. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC: Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 2004; 32: 4100-4108.
57. Cortessis VK, Thomas DC, Levine AJ, Breton CV, Mack TM, Siegmund KD, Haile RW, Laird PW: Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Human Genet 2012; 131: 1565-1589.
58. Weitzman SA, Turk PW, Milkowski DH, Kozlowski K: Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci USA 1994; 91: 1261-1264.
59. Turk PW, Laayoun A, Smith SS, Weitzman SA: DNA adduct 8-hydroxyl-2 ′-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 1995; 16: 1253-1255.
60. Donkena KV, Young CY, Tindall DJ: Oxidative stress and DNA methylation in prostate cancer. Obstet Gynecol Int 2010; 2010: 302051.
61. Bhusari SS, Dobosy JR, Fu V, Almassi N, Oberley T, Jarrard DF: Superoxide dismutase l knockdown induces oxidative stress and DNA methylation loss in the prostate. Epigenetics 2010; 5: 402-409.
62. Medici V, Shibata NM, Kharbanda KK, La-Salle JM, Woods R, Liu S, Engelberg JA, Devaraj S, Torok NJ, Jiang JX, Havel PJ, Lonnerdal B, Kim K, Halsted CH: Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease. Hepatology 2013; 57: 555-565.
63. Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A, Tosukhowong P: Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential. PLoS One 2012; 7:e37009.
64. Hitchler MJ, Domann FE: An epigenetic perspective on the free radical theory of development. Free Radic Biol Med 2007; 43: 1023-1036.